Related Experiment Video
Updated: Jan 18, 2026
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
An analysis of Russian-produced clinical practice guidelines using the RIGHT reporting checklist: The case of direct
Elena A Baybulatova1, Mikhail S Chenkurov1, Elina A Korovyakova1
1Рeoples' Friendship University of Russia Named After Patrice Lumumba (RUDN University), Moscow, Russia.
Insights
The RIGHT checklist effectively assessed Russian clinical practice guidelines for direct oral anticoagulants in COVID-19 treatment. While basic information scored well, areas like funding and quality assurance need improvement for better patient care.
Area of Science:
- Medical Guidelines Evaluation
- Health Services Research
Background:
- Russian clinical practice guidelines (CPGs) for direct oral anticoagulants (DOACs) in COVID-19 treatment and prophylaxis require quality assessment.
- Evaluating CPGs is crucial for ensuring evidence-based patient care and rational drug use.
Purpose of the Study:
- To compare the quality assessment results of Russian DOAC CPGs using the RIGHT checklist and the AGREE II instrument.
- To determine the applicability and utility of the RIGHT checklist for Russian CPGs.
Main Methods:
- Six Russian CPGs on DOACs for COVID-19, published 2020–2023, were assessed.
- The RIGHT checklist and AGREE II instrument were used for quality assessment.
- Comparative analysis of assessment results from both tools was performed.
Main Results:
- All six CPGs scored highly in 'Basic information' (56.2%-70.8%) and 'Background' (48.4%-74.0%) sections.
- Lowest scores were observed in RIGHT sections: 'Review and quality assurance' (0%-4.2%) and 'Funding and declaration management of interests' (14.6%-19.8%).
Conclusions:
- The RIGHT checklist is applicable and useful for evaluating Russian CPGs.
- The RIGHT tool enhances the depth and breadth of quality assessment, identifying specific problem areas.
- Further improvements in Russian CPGs and their implementation are necessary for optimal patient care and DOAC utilization.
Abstract:
ObjectiveThe objective of the study was to compare the results of quality assessment of Russian-produced clinical practice guidelines on the use of direct oral anticoagulants in the treatment and prophylaxis of coronavirus disease 2019 using the RIGHT checklist and AGREE II instrument.MethodsWe assessed six relevant clinical practice guidelines published between 2020 and 2023 in Russian databases using the RIGHT checklist. We compared the results of using the RIGHT tool with the results obtained using the AGREE II instrument.ResultsAll six clinical guidelines received high scores in the sections "Basic information" (range: 56.2%-70.8%) and "Background" (48.4%-74.0%). The lowest results were obtained in the sections on RIGHT: "Review and quality assurance" (0%-4.2%) and "Funding and declaration management of interests" (14.6%-19.8%).ConclusionThe RIGHT checklist was proven applicable and usable for evaluating Russian-produced clinical practice guidelines. The use of RIGHT reporting tool enriched the depth and breadth of quality assessment to identify more areas that are problematic and to critically appraise details of the problems. More efforts are needed to further improve Russian clinical practice guidelines and their implementation into clinical practice to ensure better patient care and rational use of direct oral anticoagulants.
More Related Videos
Related Concept Videos
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:19Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:26Coronary Artery Disease IV: Preventive Measures
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:10Pre-Procedural Guidelines for Assessing Blood Pressure